These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Subsequent pregnancy outcomes after complete and partial molar pregnancy, recurrent molar pregnancy, and gestational trophoblastic neoplasia: an update from the New England Trophoblastic Disease Center. Vargas R; Barroilhet LM; Esselen K; Diver E; Bernstein M; Goldstein DP; Berkowitz RS J Reprod Med; 2014; 59(5-6):188-94. PubMed ID: 24937955 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of efficacy and safety of chemotherapy in the treatment of recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis. Luo F; Li L; Gao Q; Li YX Medicine (Baltimore); 2021 Oct; 100(40):e27320. PubMed ID: 34622830 [TBL] [Abstract][Full Text] [Related]
7. A comparative study of the efficiency and safety of chemotherapy as a therapeutic method for recurrent or resistant gestational trophoblastic neoplasia: A protocol for systematic review and meta-analysis. Jiang TY; Ren JJ; Zhang Y; Zhao Y; Feng XL Medicine (Baltimore); 2021 Jun; 100(24):e26263. PubMed ID: 34128856 [TBL] [Abstract][Full Text] [Related]
9. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level. Gueye M; Kane-Gueye SM; Ndiaye-Gueye MD; Mbaye M; Diouf AA; Niang MM; Diallo M; Moreau JC BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and prognosis of ultra high-risk gestational trophoblastic neoplasia patients: A retrospective cohort study. Kong Y; Yang J; Jiang F; Zhao J; Ren T; Li J; Wang X; Feng F; Wan X; Xiang Y Gynecol Oncol; 2017 Jul; 146(1):81-86. PubMed ID: 28461032 [TBL] [Abstract][Full Text] [Related]
11. Analysis of Clinical Characteristics and Outcomes in 7 Patients with Re-recurrent Gestational Trophoblastic Neoplasia. Li B; Wan X; Liang Y; Lu B; Lu W J Reprod Med; 2016 Sep; 61(9-10):494-502. PubMed ID: 30383951 [TBL] [Abstract][Full Text] [Related]
12. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India. Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171 [TBL] [Abstract][Full Text] [Related]
13. High HIV prevalence in gestational trophoblastic neoplasia patients. Parker VL; Baker ZLI; Stone BJ; Singh K; Winter MC; Palmer JE AIDS; 2024 Jan; 38(1):69-73. PubMed ID: 37816174 [TBL] [Abstract][Full Text] [Related]
14. Immune Checkpoint Inhibitors for the Treatment of Gestational Trophoblastic Neoplasia: Rationale, Effectiveness, and Future Fertility. Salman L; Bouchard-Fortier G; Covens A Curr Treat Options Oncol; 2022 Jul; 23(7):1035-1043. PubMed ID: 35511345 [TBL] [Abstract][Full Text] [Related]
15. Premature trial discontinuation often not accurately reflected in registries: comparison of registry records with publications. Alturki R; Schandelmaier S; Olu KK; von Niederhäusern B; Agarwal A; Frei R; Bhatnagar N; Hooft L; von Elm E; Briel M J Clin Epidemiol; 2017 Jan; 81():56-63. PubMed ID: 27614277 [TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of patients with relapsed and chemo-resistant gestational trophoblastic neoplasia]. Zhou Y; Feng FZ; Xiang Y; Wan XR Zhonghua Fu Chan Ke Za Zhi; 2010 Nov; 45(11):804-7. PubMed ID: 21211275 [TBL] [Abstract][Full Text] [Related]
17. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? Sun SY; Melamed A; Goldstein DP; Bernstein MR; Horowitz NS; Moron AF; Maestá I; Braga A; Berkowitz RS Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351 [TBL] [Abstract][Full Text] [Related]
18. Second curettage versus conventional chemotherapy in avoiding unnecessary chemotherapy and reducing the number of chemotherapy courses for patients with gestational trophoblastic neoplasia: A systematic review and meta-analysis. Zhao P; Yu Y; Du M; Xu J; Lu W Int J Gynaecol Obstet; 2024 Apr; 165(1):34-42. PubMed ID: 37753799 [TBL] [Abstract][Full Text] [Related]
19. Are different methotrexate regimens as first line therapy for low risk gestational trophoblastic neoplasia more cost effective than the dactinomycin regimen used in GOG 0174? Miller CR; Chappell NP; Sledge C; Leath CA; Phippen NT; Havrilesky LJ; Barnett JC Gynecol Oncol; 2017 Jan; 144(1):125-129. PubMed ID: 27816248 [TBL] [Abstract][Full Text] [Related]